Remicade and Asacol drug interactions - from FDA reports


Drug interactions are reported among people who take Remicade and Asacol together. This study is created by eHealthMe based on reports of 2,304 people who take Remicade and Asacol from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Oct, 19, 2018

2,304 people who take Remicade, Asacol are studied.


Number of reports submitted per year:

Remicade and Asacol drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Infusion related reaction
  2. Arthralgia (joint pain)
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
1 - 6 months:
  1. Fatigue (feeling of tiredness)
  2. Infusion related reaction
  3. Nausea (feeling of having an urge to vomit)
  4. Drug ineffective
  5. Back pain
1 - 2 years:
  1. Drug ineffective
  2. Dizziness
  3. Infusion related reaction
  4. Hypertension (high blood pressure)
  5. Nausea (feeling of having an urge to vomit)
2 - 5 years:
  1. Oropharyngeal pain
  2. Pruritus (severe itching of the skin)
  3. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  4. Rhinalgia (pain in the nose)
  5. Swelling face
5 - 10 years:
  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. Viral infection
  3. Abscess (pus)
  4. Abdominal pain upper
  5. Brain mass
10+ years:
  1. Benign neoplasm (benign (non-cancerous) tumour)
  2. Benign prostatic hyperplasia (benign enlargement of the prostate)
  3. Death
  4. Peritoneal abscess
  5. Pneumonia
not specified:
  1. Infusion related reaction
  2. Drug ineffective
  3. Arthralgia (joint pain)
  4. Nausea (feeling of having an urge to vomit)
  5. Dyspnoea (difficult or laboured respiration)

Click here to view more results or personalize the results to your gender and age

Most common drug interactions by gender *:

female:
  1. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
  2. Pain
  3. Pyrexia (fever)
  4. Abdominal pain
  5. Headache (pain in head)
male:
  1. Infusion related reaction
  2. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  3. Diarrhoea
  4. Headache (pain in head)
  5. Abdominal pain

Click here to view more results or personalize the results to your gender and age

Most common drug interactions by age *:

0-1:
  1. Trisomy 21 (a chromosomal disorder that results in the presence of an additional third chromosome 21)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Abortion spontaneous (naturally occurring miscarriage)
  4. Low birth weight baby
  5. Maternal drugs affecting foetus (chemical affecting the baby before birth taken by mother)
2-9:
  1. Infusion related reaction
  2. Anaphylactic reaction (serious allergic reaction)
  3. Death
  4. Nephroblastoma (cancer of the kidneys that typically occurs in children)
  5. Cough
10-19:
  1. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Lactic acidosis (low ph in body tissues)
  5. Infusion related reaction
20-29:
  1. Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow)
  2. Infusion related reaction
  3. Arthralgia (joint pain)
  4. Weight decreased
  5. Abdominal pain
30-39:
  1. Infusion related reaction
  2. Diarrhoea
  3. Nausea (feeling of having an urge to vomit)
  4. Rash
  5. Frequent bowel movements
40-49:
  1. Infusion related reaction
  2. Drug ineffective
  3. Erythema (redness of the skin)
  4. Nausea (feeling of having an urge to vomit)
  5. Dizziness
50-59:
  1. Infusion related reaction
  2. Nausea (feeling of having an urge to vomit)
  3. Arthralgia (joint pain)
  4. Drug ineffective
  5. White blood cell count increased
60+:
  1. Rash
  2. Arthralgia (joint pain)
  3. Oropharyngeal pain
  4. Weight increased
  5. Sepsis (a severe blood infection that can lead to organ failure and death)

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you take Remicade and Asacol?


You are not alone:




Related studies

Remicade

Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from Remicade 141,872 users)

Asacol

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. (latest outcomes from Asacol 13,263 users)


Interactions between Remicade and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Asacol and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Remicade and Asacol
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Remicade and Asacol (22,604 reports studied)

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!